• Home
  • About
    • Sonnet Overview
    • Sonnet Management Team
    • Sonnet CEO Corner
  • Technology
    • Overview
    • Platform
    • Publications
  • Pipeline
    • Overview
    • SON-1010
    • SON-1210
    • SON-080
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

Trading on The Nasdaq Capital Market under the ticker symbol “PURR”

Full Press Release Here

Presentations

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Hyperliquid Strategies Inc Investor Presentation

Hyperliquid Strategies Inc Investor Presentation

Investor Presentation

Investor Presentation

RSS
© 2025 Sonnet BioTherapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap